Brianna Ayers
Family · Warrenton, ORNPI 1255953485
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,605 of the $7,491 with a category attached, or 61.5%. 18 manufacturers reported payments, led by Pfizer at 34.4% of the total. 2025 is the largest year on record at $4,015, more than ten times the $149 reported in 2022. Among family clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 227 payments — averaging $33.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$3K
- Johnson & Johnson$2K
- AbbVie$717
- UCB, Inc.$643
- Regeneron Healthcare Solutions, Inc.$476
- E.r. Squibb & Sons, L.L.C.$353
- plus $1K from 12 others
What the payments were for
- Consulting fees$2,32531%
- Speaking & faculty fees$711%
- Food & beverage$4,60561%
- Education$4897%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 6 | $2,576 |
| Johnson & Johnson(2 entities) | 88 | $1,527 |
| AbbVie | 36 | $717 |
| UCB, Inc. | 27 | $643 |
| Regeneron Healthcare Solutions, Inc. | 15 | $476 |
| E.r. Squibb & Sons, L.L.C. | 9 | $353 |
| Lilly USA, LLC | 9 | $250 |
| Amgen | 7 | $230 |
| Sanofi | 8 | $193 |
| Galderma Laboratories, L.p. | 6 | $152 |
| Novartis | 7 | $133 |
| Organon | 2 | $84 |
| Incyte Corporation | 2 | $42 |
| Arcutis Biotherapeutics, Inc. | 1 | $33 |
| Boehringer Ingelheim | 1 | $26 |
| Sun Pharmaceutical Industries Inc. | 1 | $21 |
| Biowound Solutions, Inc. | 1 | $18 |
| Kyowa Kirin, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,491 in reported general payments places this provider in the 95th percentile of 1,130 family providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 69 | $1,425 |
| Tacrolimus | 13 | $1,187 |
| Clobetasol Propionate | 27 | $1,171 |
| Triamcinolone Acetonide | 109 | $986 |
| Doxycycline Monohydrate | 30 | $819 |
| Nystatin | 20 | $207 |
| Mupirocin | 19 | $157 |
| Spironolactone | 13 | $95 |
| Minoxidil | 25 | $89 |
| Hydroxyzine Hcl | 18 | $56 |
| Cephalexin | 13 | $51 |
Paid to pharmacies, not to this prescriber.
Other family in Warrenton
- Rachel PangilinanPortland$103K
- Jodeanna SweeneyCentral Point$45K
- Lani DoserPortland$45K
- David ArnopoleMedford$38K
- Heather HermanCorvallis$34K
- Amy BartramOregon City$33K
- Leah GaedekePortland$26K
- Bobbi Lee RothTualatin$23K
- Susan ToftePortland$21K
- Leah WessenbergPortland$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.